company background image
600789 logo

Shandong Lukang PharmaceuticalLtd SHSE:600789 Stock Report

Last Price

CN¥8.49

Market Cap

CN¥7.6b

7D

-2.9%

1Y

3.4%

Updated

22 Nov, 2024

Data

Company Financials

Shandong Lukang Pharmaceutical Co.,Ltd.

SHSE:600789 Stock Report

Market Cap: CN¥7.6b

Shandong Lukang Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shandong Lukang PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥8.49
52 Week HighCN¥10.67
52 Week LowCN¥5.04
Beta0.30
11 Month Change2.78%
3 Month Change22.16%
1 Year Change3.41%
33 Year Change20.43%
5 Year Change34.55%
Change since IPO232.26%

Recent News & Updates

A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb

Nov 11
A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb

We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings

Nov 05
We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings

Recent updates

A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb

Nov 11
A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb

We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings

Nov 05
We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings

Does Shandong Lukang PharmaceuticalLtd (SHSE:600789) Have A Healthy Balance Sheet?

Sep 26
Does Shandong Lukang PharmaceuticalLtd (SHSE:600789) Have A Healthy Balance Sheet?

Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Price Is Out Of Tune With Earnings

Aug 21
Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Price Is Out Of Tune With Earnings

Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?

Jun 03
Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?

Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) Surges 26% Yet Its Low P/E Is No Reason For Excitement

May 06
Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) Surges 26% Yet Its Low P/E Is No Reason For Excitement

Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Solid Profits Have Weak Fundamentals

Apr 03
Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Solid Profits Have Weak Fundamentals

Shareholder Returns

600789CN PharmaceuticalsCN Market
7D-2.9%1.0%-0.9%
1Y3.4%-4.8%5.4%

Return vs Industry: 600789 exceeded the CN Pharmaceuticals industry which returned -4.8% over the past year.

Return vs Market: 600789 underperformed the CN Market which returned 5.4% over the past year.

Price Volatility

Is 600789's price volatile compared to industry and market?
600789 volatility
600789 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement7.2%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 600789 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600789's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19666,484Kun Dongwww.lkpc.com

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products.

Shandong Lukang Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Shandong Lukang PharmaceuticalLtd's earnings and revenue compare to its market cap?
600789 fundamental statistics
Market capCN¥7.63b
Earnings (TTM)CN¥400.68m
Revenue (TTM)CN¥6.08b

19.0x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600789 income statement (TTM)
RevenueCN¥6.08b
Cost of RevenueCN¥4.70b
Gross ProfitCN¥1.38b
Other ExpensesCN¥980.88m
EarningsCN¥400.68m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.45
Gross Margin22.72%
Net Profit Margin6.59%
Debt/Equity Ratio69.5%

How did 600789 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

24%

Payout Ratio